Clinical Trial

Developing MRI Technologies for Atrial Fibrillation

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
To measure image quality of damaged areas of the heart in patients with Atrial fibrillation using the contrast Gadopiclenol vs conventional Gadolinium-based contrast agents(GBCA)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-16; most recent amendment 2026-03-19.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-03-19
Trial Details
NCT Number NCT07083115
Lead Sponsor The Cleveland Clinic
Collaborators: Guerbet
Conditions Atrial Fibrillation (AF)
Enrollment 50 participants
Start Date 2025-01-16
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-23